Status:
COMPLETED
Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH
Lead Sponsor:
Department of Medical Services Ministry of Public Health of Thailand
Conditions:
Postpartum Hemorrhage
Cesarean Section
Eligibility:
FEMALE
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Objective: study efficacy of carbtocin versus oxytocin for prevention postpartum hemorrhage in high risk pregnancy who undergo cesarean section
Detailed Description
Randomized controlled clinical trial. Defined patient in two group. Primary outcome is evaluate additional drug use Secondary outcome is evaluated estimated blood loss, hemoglobin level
Eligibility Criteria
Inclusion
- previous history of postpartum hemorrhage
- polyhydramnios
- fetal macrosomia
- previous cesarean section
- grand multiparity
- intramural myoma
- chorioamnionitis
- prolonged premature rupture of membrane
- augmentation of labour
Exclusion
- pregnancy induce hypertension
- on anticoagulant
- placenta previa or placenta percreta
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04089176
Start Date
February 1 2019
End Date
May 31 2019
Last Update
September 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rajavithi Hospital
Bangkok, Thailand, 10400